Response to therapy assessment in intermediate-risk thyroid cancer patients: is thyroglobulin stimulation required?
I Moreno, D Hirsch, H Duskin-Bitan, T Dicker-Cohen… - Thyroid, 2020 - liebertpub.com
Introduction: The 2015 American Thyroid Association (ATA) guidelines recommend
response to therapy (RTT) assessment 1–2 years after initial treatment in differentiated …
response to therapy (RTT) assessment 1–2 years after initial treatment in differentiated …
Radioiodine refractory differentiated thyroid cancer
Y Jin, D Van Nostrand, L Cheng, M Liu… - Critical reviews in oncology …, 2018 - Elsevier
Differentiated thyroid cancer (DTC) is usually curable with surgery, radioactive iodine (RAI),
and thyroid-stimulating hormone (TSH) suppression. However, local recurrence and/or …
and thyroid-stimulating hormone (TSH) suppression. However, local recurrence and/or …
How to better stratify the risk of differentiated thyroid carcinomas: the key role of radioactive iodine therapy, age, and gender
Purpose The risk of relapse of differentiated thyroid carcinomas (DTC) and their indication
for radioactive iodine therapy (RAI) are assessed according to ATA risk stratification system …
for radioactive iodine therapy (RAI) are assessed according to ATA risk stratification system …
[HTML][HTML] Recurrence incidence in differentiated thyroid cancers and the importance of diagnostic iodine-131 scintigraphy in clinical follow-up
F Hatipoğlu, İ Karapolat, Ö Ömür, A Akgün… - Molecular imaging …, 2016 - ncbi.nlm.nih.gov
Objective: Differentiated thyroid cancers (DTC) are tumors with good prognosis. However,
local recurrence or distant metastasis can be observed. In our study, we aimed to investigate …
local recurrence or distant metastasis can be observed. In our study, we aimed to investigate …
Low-risk differentiated thyroid cancer and radioiodine remnant ablation: a systematic review of the literature
L Lamartina, C Durante, S Filetti… - The Journal of Clinical …, 2015 - academic.oup.com
Background: Radioiodine remnant ablation (RRA) has traditionally been one of the
cornerstones of differentiated thyroid cancer (DTC) treatment. The decision to use RRA in …
cornerstones of differentiated thyroid cancer (DTC) treatment. The decision to use RRA in …
[HTML][HTML] Postoperative radioiodine treatment within 9 months from diagnosis significantly reduces the risk of relapse in low-risk differentiated thyroid carcinoma
J Krajewska, M Jarzab, A Kukulska… - Nuclear Medicine and …, 2019 - Springer
Purpose Although postoperative radioiodine (RAI) therapy has been used in patients with
differentiated thyroid carcinoma (DTC) for many years, there is still lack of data defining the …
differentiated thyroid carcinoma (DTC) for many years, there is still lack of data defining the …
Is empiric 131I therapy justified for patients with positive thyroglobulin and negative 131I whole-body scanning results?
C Ma, J Xie, A Kuang - Journal of Nuclear Medicine, 2005 - Soc Nuclear Med
The long-term monitoring of patients with differentiated thyroid carcinoma (DTC) is essential
throughout the patient's life after total or nearly total thyroidectomy followed by 131I remnant …
throughout the patient's life after total or nearly total thyroidectomy followed by 131I remnant …
[HTML][HTML] Outcome of patients with differentiated thyroid cancer treated with 131-iodine on the basis of a detectable serum thyroglobulin level after initial treatment
Background: In patients with differentiated thyroid cancer (DTC) and raising serum
thyroglobulin (Tg) after total or near-total thyroidectomy and 131I remnant ablation an …
thyroglobulin (Tg) after total or near-total thyroidectomy and 131I remnant ablation an …
[HTML][HTML] The combined evaluation of clinical and biochemical data in management of patients with differentiated thyroid cancer
F Volpe, L Piscopo - European Journal of Nuclear Medicine and …, 2023 - Springer
Differentiated thyroid cancer (DTC) represents the most frequent endocrine neoplasm,
accounting for 5% of thyroid nodules [1]. The standard treatment of patients with DTC …
accounting for 5% of thyroid nodules [1]. The standard treatment of patients with DTC …
[HTML][HTML] Postoperative thyroglobulin as a yard-stick for radioiodine therapy: decision tree analysis in a European multicenter series of 1317 patients with differentiated …
Purpose An accurate postoperative assessment is pivotal to inform postoperative 131I
treatment in patients with differentiated thyroid cancer (DTC). We developed a predictive …
treatment in patients with differentiated thyroid cancer (DTC). We developed a predictive …